Business Context and Reporting Period
This Form 6-K filing by PainReform Ltd. (PRFX) covers the month of February 2023, with a specific reporting date of February 7, 2023. The company is a foreign private issuer based in Tel Aviv, Israel, and files annual reports on Form 20-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate event rather than a financial statement.
Material Changes
On February 7, 2023, PainReform Ltd. announced it received an extension from the Nasdaq Stock Market to meet the Minimum Bid Price Requirement. This is a material compliance event regarding the company's continued listing status.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future operations, or a discussion of general business risks. The primary contingency addressed is the risk of delisting due to failure to meet the minimum bid price, which has been temporarily mitigated by the granted extension.
Investor Verification Checklist
- Verify the specific duration of the Nasdaq extension granted to PainReform Ltd.
- Confirm the current minimum bid price requirement and the company's recent trading price history.
- Review the attached press release (Exhibit 99.1) for details on the company's plan to regain compliance.
- Check subsequent filings for updates on the company's stock price and compliance status.